SPATA31A5
gene geneOn this page
Also known as OTTHUMG00000013204
Summary
SPATA31A5 (SPATA31 subfamily A member 5, HGNC:32005) is a protein-coding gene on chromosome 9q12, encoding Spermatogenesis-associated protein 31A5 (Q5VU36). May play a role in spermatogenesis.
Predicted to be involved in cell differentiation and spermatogenesis. Predicted to be located in membrane.
Source: NCBI Gene 727905 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 63 total
- MANE Select transcript:
NM_001113541
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:32005 |
| Approved symbol | SPATA31A5 |
| Name | SPATA31 subfamily A member 5 |
| Location | 9q12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | OTTHUMG00000013204 |
| Ensembl gene | ENSG00000276581 |
| Ensembl biotype | protein_coding |
| Entrez | 727905 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000437823
RefSeq mRNA: 1 — MANE Select: NM_001113541
NM_001113541
CCDS: CCDS47970
Canonical transcript exons
ENST00000437823 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001658605 | 60916765 | 60920653 |
| ENSE00001785279 | 60915823 | 60915880 |
| ENSE00003722508 | 60916449 | 60916509 |
| ENSE00003740628 | 60914407 | 60914624 |
Expression profiles
Bgee: expression breadth tissue_specific, 4 present calls, max score 43.46.
Top tissues by expression
125 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 43.46 | gold quality |
| testis | UBERON:0000473 | 41.83 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 37.56 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| right testis | UBERON:0004534 | 35.70 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 32.30 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| prefrontal cortex | UBERON:0000451 | 32.08 | gold quality |
| muscle tissue | UBERON:0002385 | 32.07 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| primary visual cortex | UBERON:0002436 | 29.99 | gold quality |
| monocyte | CL:0000576 | 29.92 | gold quality |
| blood | UBERON:0000178 | 29.88 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| leukocyte | CL:0000738 | 29.71 | gold quality |
| liver | UBERON:0002107 | 29.12 | gold quality |
| endocervix | UBERON:0000458 | 28.90 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| frontal cortex | UBERON:0001870 | 27.75 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| placenta | UBERON:0001987 | 27.38 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 27.32 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.16 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
23 targeting SPATA31A5, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-4747-5P | 100.00 | 67.90 | 2681 |
| HSA-MIR-5196-5P | 100.00 | 67.98 | 2761 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548D-3P | 99.87 | 70.67 | 4362 |
| HSA-MIR-548BB-3P | 99.86 | 70.58 | 4354 |
| HSA-MIR-548AC | 99.84 | 70.77 | 4351 |
| HSA-MIR-548H-3P | 99.84 | 70.80 | 4349 |
| HSA-MIR-548Z | 99.84 | 70.80 | 4349 |
| HSA-MIR-6505-5P | 99.73 | 69.25 | 1595 |
| HSA-MIR-6833-5P | 99.50 | 68.93 | 1161 |
| HSA-MIR-519A-2-5P | 98.78 | 71.74 | 1401 |
| HSA-MIR-520B-5P | 98.78 | 71.74 | 1401 |
| HSA-MIR-4752 | 98.71 | 68.04 | 833 |
| HSA-MIR-4684-5P | 98.29 | 67.99 | 1650 |
| HSA-MIR-6810-5P | 98.29 | 66.21 | 975 |
| HSA-MIR-7113-5P | 97.88 | 67.33 | 1735 |
| HSA-MIR-376C-3P | 97.63 | 68.88 | 1263 |
| HSA-MIR-3190-3P | 97.61 | 66.95 | 1406 |
| HSA-MIR-5586-3P | 95.51 | 67.00 | 805 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Spata31 | ENSMUSG00000056223 |
| rattus_norvegicus | Spata31 | ENSRNOG00000018202 |
Paralogs (13): SPATA31C2 (ENSG00000177910), SPATA31E1 (ENSG00000177992), SPATA31A6 (ENSG00000185775), SPATA31D3 (ENSG00000186788), SPATA31F3 (ENSG00000187791), SPATA31D4 (ENSG00000189357), SPATA31A1 (ENSG00000204849), SPATA31F1 (ENSG00000205108), SPATA31D1 (ENSG00000214929), SPATA31C1 (ENSG00000230246), (ENSG00000251545), SPATA31A3 (ENSG00000275969), SPATA31A7 (ENSG00000276040)
Protein
Protein identifiers
Spermatogenesis-associated protein 31A5 — Q5VU36 (reviewed: Q5VU36)
Alternative names: Protein FAM75A5
All UniProt accessions (1): Q5VU36
UniProt curated annotations — full annotation on UniProt →
Function. May play a role in spermatogenesis.
Subcellular location. Membrane.
Similarity. Belongs to the SPATA31 family.
RefSeq proteins (1): NP_001107013* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR027970 | SPATA31-like | Domain |
| IPR039509 | SPATA31 | Domain |
Pfam: PF14650, PF15371
UniProt features (16 total): compositionally biased region 7, region of interest 7, chain 1, transmembrane region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5VU36-F1 | 39.32 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 14 (showing top):
GOBP_MALE_GAMETE_GENERATION, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, MIR548D_3P, MIR548H_3P_MIR548Z, MIR548BB_3P, MIR548AC, MIR519A_2_5P_MIR520B_5P, MIR4684_5P, MIR6833_5P, MIR5586_3P, GOBP_SEXUAL_REPRODUCTION, GOBP_REPRODUCTIVE_PROCESS, GOBP_MULTICELLULAR_ORGANISMAL_REPRODUCTIVE_PROCESS, chr9q12
GO Biological Process (2): spermatogenesis (GO:0007283), cell differentiation (GO:0030154)
GO Molecular Function (0):
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| cellular developmental process | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
12 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SPATA31A5 | PPIAL4D | F5H284 | 720 |
| SPATA31A5 | AMER1 | Q5JTC6 | 321 |
| SPATA31A5 | TMEM200B | Q69YZ2 | 310 |
| SPATA31A5 | FRMD6 | Q96NE9 | 159 |
| SPATA31A5 | LGR5 | O75473 | 155 |
| SPATA31A5 | SPATA31A6 | Q5VVP1 | 0 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KLHL22 | TRAV18 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (1): SPATA31A5 (Affinity Capture-MS)
ESM2 similar proteins: A0A096LP49, A6NGG8, A6NNH2, B1ASB6, B4DYI2, B6VQA5, C0HKD1, C0HKD2, C0HKD3, D2J0Y4, D6RGX4, E9QAF0, P0C874, P0DKV0, Q149B8, Q3KR64, Q4R736, Q4V8B5, Q5TZJ5, Q5VU36, Q5VVP1, Q5VWK0, Q5VYM1, Q5VYP0, Q63HN1, Q658T7, Q68A65, Q6NS69, Q6NXZ1, Q6PAC4, Q6ZQQ2, Q6ZU69, Q6ZUB0, Q6ZUB1, Q7TSA6, Q80X53, Q86Y26, Q8BHP2, Q8BHW6, Q8C0D9
Diamond homologs: B4DYI2, B6VQA5, E9QAF0, P0C874, P0DKV0, Q5TZJ5, Q5VU36, Q5VVP1, Q5VYP0, Q6ZQQ2, Q6ZUB0, Q6ZUB1, Q8IWB4, A6NFR6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
63 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 55 |
| Likely benign | 8 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
747 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:60915774:T:G | acceptor_gain | 1.0000 |
| 9:60915777:T:A | acceptor_gain | 1.0000 |
| 9:60915767:A:AG | acceptor_gain | 0.9900 |
| 9:60915769:T:A | acceptor_gain | 0.9900 |
| 9:60915769:T:TA | acceptor_gain | 0.9900 |
| 9:60915773:A:AG | acceptor_gain | 0.9900 |
| 9:60915773:ATCTT:A | acceptor_gain | 0.9900 |
| 9:60915777:T:TA | acceptor_gain | 0.9900 |
| 9:60915785:C:CA | acceptor_gain | 0.9900 |
| 9:60915787:C:CA | acceptor_gain | 0.9900 |
| 9:60915805:C:G | acceptor_gain | 0.9900 |
| 9:60916447:A:AG | acceptor_gain | 0.9900 |
| 9:60916447:AGCT:A | acceptor_gain | 0.9900 |
| 9:60916448:G:GA | acceptor_gain | 0.9900 |
| 9:60916448:G:GG | acceptor_gain | 0.9900 |
| 9:60916448:GCTG:G | acceptor_gain | 0.9900 |
| 9:60916507:GAG:G | donor_gain | 0.9900 |
| 9:60914620:GAAAG:G | donor_gain | 0.9800 |
| 9:60914623:AGGT:A | donor_loss | 0.9800 |
| 9:60914624:GGTA:G | donor_loss | 0.9800 |
| 9:60914625:G:GA | donor_loss | 0.9800 |
| 9:60914626:T:G | donor_loss | 0.9800 |
| 9:60915767:ATT:A | acceptor_gain | 0.9800 |
| 9:60915768:T:G | acceptor_gain | 0.9800 |
| 9:60915801:C:CA | acceptor_gain | 0.9800 |
| 9:60916448:GCT:G | acceptor_gain | 0.9800 |
| 9:60916507:GAGGT:G | donor_loss | 0.9800 |
| 9:60916508:AGGT:A | donor_loss | 0.9800 |
| 9:60916510:GTGAG:G | donor_loss | 0.9800 |
| 9:60916511:T:G | donor_loss | 0.9800 |
AlphaMissense
8801 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:60917702:T:C | F416L | 0.974 |
| 9:60917704:C:A | F416L | 0.974 |
| 9:60917704:C:G | F416L | 0.974 |
| 9:60917708:G:C | G418R | 0.922 |
| 9:60917795:T:C | F447L | 0.921 |
| 9:60917797:C:A | F447L | 0.921 |
| 9:60917797:C:G | F447L | 0.921 |
| 9:60918893:T:A | W813R | 0.921 |
| 9:60918893:T:C | W813R | 0.921 |
| 9:60918895:G:C | W813C | 0.904 |
| 9:60918895:G:T | W813C | 0.904 |
| 9:60917705:T:A | W417R | 0.903 |
| 9:60917705:T:C | W417R | 0.903 |
| 9:60918827:T:C | F791L | 0.899 |
| 9:60918829:C:A | F791L | 0.899 |
| 9:60918829:C:G | F791L | 0.899 |
| 9:60919493:T:C | F1013L | 0.844 |
| 9:60919495:T:A | F1013L | 0.844 |
| 9:60919495:T:G | F1013L | 0.844 |
| 9:60917703:T:C | F416S | 0.835 |
| 9:60917725:C:A | H423Q | 0.835 |
| 9:60917725:C:G | H423Q | 0.835 |
| 9:60917707:G:C | W417C | 0.824 |
| 9:60917707:G:T | W417C | 0.824 |
| 9:60918161:T:C | F569L | 0.822 |
| 9:60918163:T:A | F569L | 0.822 |
| 9:60918163:T:G | F569L | 0.822 |
| 9:60917726:A:C | S424R | 0.821 |
| 9:60917728:C:A | S424R | 0.821 |
| 9:60917728:C:G | S424R | 0.821 |
dbSNP variants (sampled 300 via entrez): RS1001769542 (9:60914118 A>C), RS1039609620 (9:60915342 GGAGT>G), RS1047180411 (9:60916368 C>T), RS1156550515 (9:60914882 T>A), RS1157212914 (9:60917502 C>A), RS1157473292 (9:60913777 A>G), RS1157902682 (9:60915811 C>A,T), RS1158253371 (9:60916607 G>A), RS1158734533 (9:60915752 C>A,T), RS1158832348 (9:60916921 G>A), RS1159056764 (9:60913687 A>T), RS1160480500 (9:60914358 C>T), RS1160539038 (9:60915369 T>G), RS1160913799 (9:60915071 G>A,C), RS1161833993 (9:60915187 CTGTGTGTGTGTGTGTGTGTG>C,CTG,CTGTG,CTGTGTG,CTGTGTGTG,CTGTGTGTGTG,CTGTGTGTGTGTG,CTGTGTGTGTGTGTG,CTGTGTGTGTGTGTGTG,CTGTGTGTGTGTGTGTGTG,CTGTGTGTGTGTGTGTGTGTGTG,CTGTGTGTGTGTGTGTGTGTGTGTG,CTGTGTGTGTGTGTGTGTGTGTGTGTG,CTGTGTGTGTGTGTGTGTGTGTGTGTGTG,CTGTGTGTGTGTGTGTGTGTGTGTGTGTGTG,CTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTG,CTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTG,CTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTG,CTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTG,CTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTG)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
2 total (human), top 2 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cadmium | increases abundance, increases expression | 1 |
| Cadmium Chloride | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.